-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BjHFly+3du1YrxkKI0zme97zz2f+vqhiMVwmLdn+6RH0GOPyk0xs1gszPphAYfAb kTRwoInnwAn0EOtFoDs9Hw== 0000950115-97-000891.txt : 19970604 0000950115-97-000891.hdr.sgml : 19970604 ACCESSION NUMBER: 0000950115-97-000891 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970603 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MED-DESIGN CORP CENTRAL INDEX KEY: 0000943736 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232771475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-48795 FILM NUMBER: 97618531 BUSINESS ADDRESS: STREET 1: NORTH AMERICAN BLDG STE 310 STREET 2: 121 S BROAD ST CITY: PHILADELPHIA STATE: PA ZIP: 19107 BUSINESS PHONE: 2157352700 MAIL ADDRESS: STREET 1: 123 SOUTH BROAD ST STREET 2: SUITE 310 CITY: PHILADELPHIA STATE: PA ZIP: 19107 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOTICH MICHAEL J CENTRAL INDEX KEY: 0001007683 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 583926100 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 2810 BUNSEN AVE STREET 2: C/O MDC RESEARCH LTD CITY: VENTURA STATE: CA ZIP: 93003 BUSINESS PHONE: 8053390375 MAIL ADDRESS: STREET 1: MDC RESEARCH LTD STREET 2: 2810 BUNSEN AVE CITY: VENTURA STATE: CA ZIP: 93003 SC 13G 1 OMB Approval UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: December 31, 1997 Washington, D.C. 20549 Estimated average burden hours per response.....14.90
Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* The Med-Design Corporation -------------------------- (Name of Issue) Common Stock ----------------------------- (Title of Class of Securities) 583926 10 0 -------------- (CUSIP Number) Check the following box if a fee is being paid with this statement ____. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SEC1745 (2-95) Page 1 of 4 CUSIP NO. 583926 10 0 13G PAGE 2 OF 4 PAGES 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Michael Botich 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* A ____ N/A B ____ 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States of America 5. SOLE VOTING POWER 401,592 Shares of Common Stock (includes stock options to purchase 2,000 shares) 6. SHARED VOTING POWER N/A 7. SOLE DISPOSITIVE POWER 401,592 Shares of Common Stock (includes stock options to purchase 2,000 shares) 8. SHARED DISPOSITIVE POWER N/A 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 401,592 Shares of Common Stock (includes stock options to purchase 2,000 shares) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.8% 12. TYPE OF REPORTING PERSON* IN *SEE INSTRUCTION BEFORE FILING OUT! SEC1745 (2-95) Page 2 of 4 CUSIP No. 583926 10 0 13G Page 3 of 4 Pages Item 1. The issuer of the securities to which this statement relates is The Med-Design Corporation ("Med-Design"). Med-Design's principal executive offices are located at the North American Building, Suite 310, 121 South Broad Street, Philadelphia, Pennsylvania 19107. Item 2. This statement is filed by Michael Botich, a citizen of the United States of America, whose business address is c/o MDC Research Ltd., 2810 Bunsen Avenue, Ventura, California 93003. The title of the class of securities to which this statement relates is Common Stock, having a CUSIP number of 583926 10 0. Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: N/A Item 4. Ownership See item nos. 5 through 11 on the second part of the cover sheet. Item 5. Ownership of Five Percent or Less of a Class N/A Item 6. Ownership of More than Five Percent on Behalf of Another Person N/A Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company N/A Item 8. Identification and Classification of Members of the Group N/A Item 9. Notice of Dissolution of Group N/A Item 10. Certification N/A SEC1745 (2-95) Page 3 of 4 CUSIP No. 583926 10 0 13G Page 4 of 4 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. ----------------------------------- Date /s/ Michael Botich ----------------------------------- Signature Michael Botich Senior Vice President, R&D ----------------------------------- Name/Title SEC1745 (2-95) Page 4 of 4 -----END PRIVACY-ENHANCED MESSAGE-----